Search Results
Dec 01, 2025, 08:45 ET Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
tumor killing while potentially reducing off-target lung toxicity—a critical differentiating factor that could expand treatment options for patients unable to tolerate current therapies.ATNM-400's Pan Tumor Potential Extends to Prostate and Lung CancerIn addition to breast cancer, ATNM-400
More news about: Actinium Pharmaceuticals, Inc.
Dec 01, 2025, 06:00 ET IDEAYA Biosciences Announces IND Clearance for IDE034, a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types
patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck and ovarian/gynecological cancers. Based on the Human Protein Atlas database, B7H3/PTK7 has been reported to be co-expressed in lung, colorectal, and head and neck cancers at approximately 30%, 46% and
More news about: IDEAYA Biosciences, Inc.
Dec 01, 2025, 06:00 ET Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
six months) versus placebo over 52 weeks, with a primary endpoint of reduction in annualized asthma exacerbation rate and additional assessments of lung function, symptom control, and quality of life. These replicate studies share nearly identical designs but differ slightly in geographic distribution
More news about: Generate:Biomedicines
Dec 01, 2025, 06:00 ET Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
six months) versus placebo over 52 weeks, with a primary endpoint of reduction in annualized asthma exacerbation rate and additional assessments of lung function, symptom control, and quality of life. These replicate studies share nearly identical designs but differ slightly in geographic distribution
More news about: Generate:Biomedicines
Dec 01, 2025, 05:04 ET National Health Orgs: Flu Shots Critical for Individuals with Diabetes, Heart and Lung Disease
1-800-AHA-USA1.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Dec 01, 2025, 05:00 ET 'Beer Belly' Linked to Heart Damage in Men
right ventricle, which pumps blood to the lungs. This may reflect early cardiac stress on the heart related to how abdominal fat affects breathing and lung pressure.Obesity also was linked to subtle heart tissue changes in men, detectable only with advanced
More news about: Radiological Society of North America (RSNA)
Dec 01, 2025, 03:15 ET aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR
that, "aTyr Pharma said on Monday its experimental drug had failed to meet the main goal in a late-stage study testing it in patients with a type of lung disease known as pulmonary sarcoidosis, which impacts the lungs and lymph nodes." Based on this news, shares of aTyr traded down by more than 81% in
More news about: DJS Law Group LLP
Nov 30, 2025, 09:46 ET TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
clinical trial of TTI-101 in idiopathic pulmonary fibrosis. The study was designed to assess safety, pharmacokinetics, and exploratory outcomes related to lung function. After reviewing the preliminary safety data and exploratory efficacy results, including changes in Forced Vital Capacity (FVC), the Company
More news about: Faruqi & Faruqi, LLP
Nov 28, 2025, 00:13 ET The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma
is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as non-small cell lung cancer (NSCLC), breast cancer (BC), gastric cancer (GC), gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 27, 2025, 17:09 ET Keep Your Respiratory Health Strong This Season With VARON Black Friday Offers
holiday season approaches, respiratory health becomes a top priority for individuals living with chronic conditions such as COPD, sleep apnea, or other lung diseases. VARON,
More news about: Varon oxygen concentrator
Nov 27, 2025, 06:30 ET Intratumoral Cancer Therapies Market to Reach USD 630.7 Million by 2033 as Next-Generation Localized Immunotherapies Transform Solid Tumor Treatment
localized immune activation, oncolysis, and cytokine or gene delivery within tumors.By Cancer Type (Melanoma, Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Others)MelanomaMelanoma remained the largest clinical focus, representing 36% of the market
More news about: DataM Intelligence 4 Market Research LLP
Nov 27, 2025, 00:00 ET GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
of blood, the test detects signals associated with multiple cancers. A major upgrade—expanding from 6 detectable cancers to 10 cancers (colorectal, lung, esophageal, liver, ovarian, pancreatic, biliary, breast, gastric, and head-and-neck)—is planned for January 2026.About GC GenomeGC
More news about: GC Genome
Nov 26, 2025, 06:30 ET Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference
responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
More news about: Nuvalent, Inc.
Nov 26, 2025, 05:39 ET Secure Reliable Oxygen Support This Holiday Season: Last Five Days of Black Friday 2025
-- Winter and the holiday season bring increased respiratory challenges, particularly for individuals with chronic conditions such as COPD or other lung diseases. To help families and caregivers protect their health during festive gatherings,
More news about: Varon oxygen concentrator
Nov 25, 2025, 22:51 ET FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
antibody-dependent cell-mediated cytotoxicity (ADCC). UNLOXCYT also spares PD-L2, which may help preserve immune tolerance in non-tumor tissues, such as lung and liver, potentially limiting off-target effects and imARs."The longer-term results confirm that UNLOXCYT represents an advancement in the
More news about: Sun Pharma
Nov 25, 2025, 08:45 ET VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
https://doi.org/10.3390/biom130812552. Couraud S, et al Baseline values of circulating nucleosomes in Lung Cancer: NUCLEO-LUNG study. ELCC
More news about: VolitionRx Limited
Nov 25, 2025, 08:45 ET VolitionRx Limited annonce le premier contrat de vente des tests Nu.Q® Cancer pour la validation clinique en vue d'une utilisation pratique de soins courants
https://doi.org/10.3390/biom130812552. Couraud S, et al Baseline values of circulating nucleosomes in Lung Cancer: NUCLEO-LUNG study. ELCC
More news about: VolitionRx Limited
Nov 25, 2025, 08:11 ET Immorta Bio Announces Publication of International Patent Application for SenoVax™, a First-in-Class Senolytic Immunotherapy
first-in-class senolytic immunotherapy, which has demonstrated potent reduction of lung, breast, brain, skin, and pancreatic cancers in established in vivo models[2]. SenoVax™ is also the subject of FDA submission of IND #30745 for advanced lung cancer[3]."SenoVax™ is a true first-in-class immunotherapy," said
More news about: Immorta Bio Inc.
Nov 25, 2025, 08:04 ET Virginia Cancer Specialists Expands Lung Cancer and Thoracic Oncology Program, Welcomes Thoracic Surgeon Christopher R. Johnson, MD
such as the Medtronic Optimizing Lung Cancer Care Fellowship and the AATS/Intuitive Thoracic Robotics initiative. He is also a proud member of leading professional societies, including The Society of Thoracic Surgeons, the International Association for the Study of Lung Cancer, and the Eastern Cardiothoracic
More news about: Virginia Cancer Specialists
Nov 25, 2025, 07:45 ET Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models
expanding clinical reach for its DCCT platform through collaborations with leading investigators, including Dr. Steven Dubinett (UCLA) for non-small cell lung cancer and Dr. Xiaolin Zi (UC Irvine) for prostate cancer."Lunai's dendritic cell approach has the potential to overcome longstanding barriers
More news about: Lunai Bioworks Inc.
Nov 25, 2025, 07:00 ET Impilo Expands Digital Health Offerings Through Partnership with Eko Health, Featuring the Eko CORE 500™ Digital Stethoscope
hear, see, and detect more during every patient encounter.When paired with the Eko App, clinicians can visualize waveforms, analyze heart and lung sounds, and access AI-supported insights, helping to elevate diagnostic confidence and streamline patient assessments.Disclaimer: AFib
More news about: Impilo
Nov 24, 2025, 21:21 ET The Inner Circle acknowledges, Ayana Allard-Picou, MD, FACS, FSSO as a Pinnacle Lifetime Member
care.Dr. Allard-Picou's extensive experience encompasses a wide range of oncology surgeries, including esophageal, thyroid and para-thyroid, breast, lung, and pancreatic cancers. Her compassionate approach to patient care is informed by her personal experiences, which enhance her empathy and dedication
More news about: The Inner Circle
Nov 24, 2025, 19:01 ET UT Health San Antonio scientists launch innovative therapy study to help Parkinson's patients swallow safely
breakdown can cause food or liquid to move more slowly, get held up or even enter the airway – called aspiration – which can lead to persistent coughing and lung infections. By targeting these brain-muscle connections with structured swallowing therapy, Carnaby and her team aim to retrain and bolster the physiological
More news about: UT Health San Antonio
Nov 24, 2025, 16:30 ET Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
starting treatment cycles is recommended for patients who develop Grade 3 or 4 neutropenia.Severe, life-threatening, or fatal interstitial lung disease (ILD) or pneumonitis can occur in patients treated with Verzenio and other CDK4/6 inhibitors. In Verzenio-treated patients in EBC (monarchE),
More news about: Eli Lilly and Company
Nov 24, 2025, 16:01 ET Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
More news about: Nuvalent, Inc.